Table 5.
Clinical stage of thymic epithelial tumours: International Association for the Study of Lung Cancer/International Thymic Malignancy Interest Group tumor-node-metastasis
|
Stage
|
|
Description
|
| Primary tumor (T) | ||
| T1 | T1a | Encapsulated or unencapsulated, with or without extension into mediastinal fat |
| T1b | Extension into mediastinal pleura | |
| T2 | Direct invasion of the pericardium (partial or full thickness) | |
| T3 | Direct invasion of the lung, brachiocephalic vein, superior vena cava, chest wall, phrenic nerveand/or hilar (extrapericardial) pulmonary vessels | |
| T4 | Direct invasion of the aorta, main pulmonary artery, myocardium, trachea, or esophagus | |
| Lymph nodes (N) | ||
| N0 | No nodal involvement | |
| N1 | Anterior (perithymic) lymph nodes (IASLC levels 1, 3a, 6 and/or supradiaphragmatic/inferior phrenic/pericardial) | |
| N2 | Deep cervical or intrathoracic nodes (IASLC levels 2, 4, 5, 7, 10 and/or internal mammary nodes) | |
| Distant metastasis (M) | ||
| M0 | No pleural, pericardial, or distant metastases | |
| M1 | M1a | Pleural or pericardial nodules |
| M1b | Pulmonary intraparenchymal nodule or distant organ metastasis | |
| TNM stage | MASOKA-KOGA stage | |
| I | T1N0M0 | I, IIA, IIB, III |
| II | T2N0M0 | III |
| IIIA | T3N0M0 | III |
| IIIB | T4N0M0 | III |
| IVA | Any T, N0-1, M0-1a | IVA, IVB |
| IVB | Any T, N0-2, M0-1b | IVB |
IASLC: International Association for the Study of Lung Cancer; TNM: Tumor-node-metastasis.